Published in QJM on March 01, 2005
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Advances in glucocorticoid-induced osteoporosis. Curr Rheumatol Rep (2011) 1.06
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol (2009) 0.97
A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int (2010) 0.94
Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review. Osteoporos Int (2013) 0.93
Bone health in multiple sclerosis. Osteoporos Int (2011) 0.90
Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids. J Gen Intern Med (2013) 0.90
The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects. Arthritis Res Ther (2014) 0.87
Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87
Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Ther (2009) 0.85
Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. PLoS One (2013) 0.83
Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis (2009) 0.83
Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int (2010) 0.81
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment. Eur Spine J (2006) 0.80
In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells. Steroids (2011) 0.80
Treatment of osteopenia. Rev Endocr Metab Disord (2012) 0.79
Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol (2006) 0.78
A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children. Semin Arthritis Rheum (2014) 0.78
Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report. J Med Case Rep (2012) 0.78
Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients. Osteoporos Int (2014) 0.77
A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures. Bonekey Rep (2014) 0.76
Prevention and treatment of bone changes associated with exposure to glucocorticoids. Curr Osteoporos Rep (2013) 0.76
Is real world evidence influencing practice? A systematic review of CPRD research in NICE guidances. BMC Health Serv Res (2016) 0.75
Comorbidities: glucocorticoids and osteoporosis: predicting fracture risk. Nat Rev Rheumatol (2010) 0.75
Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis. Osteoporos Int (2009) 0.75
Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone. Springerplus (2015) 0.75
Effects of 1,25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis. Exp Ther Med (2017) 0.75
[Prophylaxis and therapy of the glucocorticoid-induced osteoporosis - a review of recent guidelines]. Wien Klin Wochenschr (2011) 0.75
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum (2007) 4.97
Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
Bone density screening for osteoporosis. Lancet (1990) 3.87
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Bone densitometry in clinical practice. BMJ (1995) 3.48
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94
Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis (2006) 2.86
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54
Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Use of statins and risk of fractures. JAMA (2001) 2.47
Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35
Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord (2001) 2.30
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum (2006) 2.28
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J (2005) 2.24
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford) (2005) 2.23
Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol (1998) 2.22
Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19
Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev (2004) 2.19
Vitamin D and skeletal health in infancy and childhood. Osteoporos Int (2014) 2.16
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int (2005) 2.15
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) (2005) 2.11
Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Community Health (1992) 2.11
Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study). Ann Rheum Dis (2004) 2.10
Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol (2006) 2.02
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice. Rheumatology (Oxford) (2007) 2.01
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Are rates of ageing determined in utero? Age Ageing (1998) 1.95
Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95
Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing (1989) 1.94
Radiographic assessment of osteoarthritis in population studies: whither Kellgren and Lawrence? Osteoarthritis Cartilage (1993) 1.88
A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum (2004) 1.87
Studies on the role of the morphological constituents of the microsome fraction from rat liver in protein synthesis. Biochem J (1964) 1.86
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol (1998) 1.85
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int (2010) 1.83
Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ (1988) 1.83
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women. Bone (2012) 1.82
Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res (2001) 1.82
Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (2013) 1.81